Related by context. All words. (Click for frequent words.) 73 Papillary 72 prostate carcinoma 72 papillary renal cell carcinoma 72 pathologic diagnosis 72 urothelial carcinoma 72 urothelial 71 LHRH receptor positive 71 Endometrial 70 Histopathologic 70 Histological 70 metaplasia 70 nodal metastasis 70 syngeneic 70 immunohistochemical analysis 70 Immunohistochemical staining 70 pT2 70 hyperplastic 69 pathologic examination 69 leiomyomas 69 histological subtype 69 immunohistochemical staining 69 metastatic malignant 69 Synovial 69 HER2 expression 69 Serum concentrations 69 grade squamous intraepithelial 69 mucinous 69 Histologic 69 mesenteric 69 T1a 69 interstitial fibrosis 69 endometrioid 69 gastric adenocarcinoma 69 ductal adenocarcinoma 69 colorectal carcinoma 68 TIMP 68 cisplatin resistant 68 tonsillar 68 Adenomas 68 hematoxylin eosin original 68 transabdominal 68 underwent surgical resection 68 intrahepatic 68 thyroid carcinoma 68 aminotransferase 68 T1c 68 normal karyotype 68 pituitary adenomas 68 immunostaining 68 Histopathologic examination 68 pT3 68 gadolinium enhanced 68 DU# [002] 68 parathyroid carcinoma 68 Autoantibodies 68 nonmetastatic 68 TIMP 1 68 breast carcinoma 68 Upregulation 68 Estrogen Receptor 68 bronchoalveolar lavage BAL 68 CC genotype 68 HGPIN 68 pulmonary metastases 68 histologic examination 67 histologically confirmed 67 TRAIL R1 67 histopathologic examination 67 epididymal 67 IIIb 67 Squamous 67 pretransplant 67 Ectopic 67 Polymorphisms 67 cervical lymph node 67 histologic subtype 67 intracerebral 67 lactate dehydrogenase LDH 67 NMIBC 67 hepatocellular carcinomas 67 downregulates 67 pancreatic carcinoma 67 cervical lymph nodes 67 multicentric 67 renal pelvis 67 thymectomy 67 colorectal adenocarcinoma 67 leiomyoma 67 Histologically 67 colon carcinoma 67 intraepithelial neoplasia 67 situ LCIS 67 immunohistochemical 67 bronchoalveolar lavage fluid 67 Immunohistochemical analysis 67 inducible nitric oxide synthase 67 micrometastasis 67 Lymphocytic 67 COL#A# 67 Soft Tissue Sarcoma 67 cell adhesion molecule 67 Trichophyton rubrum 67 histologic findings 66 undergoing radical cystectomy 66 colorectal adenoma 66 Adenoviral 66 mesangial 66 Oropharyngeal 66 carcinoma HCC 66 metastatic neuroendocrine tumors 66 underwent resection 66 proximal tubule 66 FDG uptake 66 Ischemic 66 lymphomas leukemias 66 BRAF V#E 66 Ultrasonographic 66 metalloproteinase 66 pleomorphic 66 peritumoral 66 adenomatous 66 papillary carcinoma 66 immunoreactive 66 HCT# 66 appendiceal 66 NSCLC tumors 66 Antigen Specific 66 liver metastasis 66 wedge resection 66 Adenoma 66 fibroma 66 metastatic gastric 66 elevated transaminases 66 hypermethylated 66 assay detects 66 histologically 66 Supplemental Figure 66 esophagogastric junction 66 Hypertrophy 66 seminal vesicle 66 aplastic anemia AA 66 Figure 2C 66 pituitary adenoma 66 Histologic examination 66 RRM1 66 essential thrombocythemia ET 66 cytologically confirmed 66 intestinal metaplasia 66 occlusive disease 66 xenograft model 66 biliary tract cancer 66 nonvascular 66 Elevated serum 66 gene polymorphism 66 Macrophage 66 GSTP1 66 bronchoalveolar lavage 66 hip osteonecrosis avascular 66 constitutively expressed 66 LV ejection fraction 66 esophageal carcinoma 66 gastric cardia 66 pancreatic prostate 66 tumorigenicity 66 intraepithelial 66 Non Alcoholic Steatohepatitis 66 lung esophageal 66 distal femur 66 cholelithiasis 66 glutamic acid decarboxylase 66 retroperitoneal 65 Sezary syndrome 65 hamartoma 65 ABCB1 65 hypervascular 65 EGFR HER2 65 lymphangiogenesis 65 radiosensitivity 65 TRUS 65 papillary thyroid carcinoma 65 underwent radical cystectomy 65 malignant ovarian 65 hypoplasia 65 uterine cervix 65 acyltransferase 65 complement inhibitor eculizumab 65 thymoma 65 hepatoma 65 steroidogenesis 65 lymphadenopathy 65 glycated 65 morphometry 65 endoscopic ultrasonography 65 unresectable tumors 65 myelodysplastic myeloproliferative diseases 65 artery stenosis 65 ductal carcinomas 65 acute myeloid 65 hamartomas 65 HepG2 cells 65 multidetector computed tomography 65 dorsal root ganglion 65 Subgroup analysis 65 hypointense 65 Hurthle cell 65 completely resected 65 murine model 65 Fibroblast 65 exocrine 65 seminal vesicles 65 benign neoplasms 65 CTEPH 65 alveolar epithelial cells 65 isoenzyme 65 benign prostatic hyperplasia enlarged 65 tumor xenograft models 65 supratentorial 65 metastatic carcinoma 65 biliary tract 65 total thyroidectomy 65 Figure 1C 65 renal cysts 65 radiotherapy RT 65 Streptococcus agalactiae 65 parenchymal 65 Secretase 65 Advanced Renal Cell 65 1beta 65 clinicopathologic 65 immunoblotting 65 submucosal 65 K ras mutations 65 mutated K ras 65 transitional cell carcinoma 65 polyposis 65 insertional 65 sarcomatoid 65 renal cortical 65 extracapsular extension 65 Multiple Myeloma MM 65 Adenocarcinoma 65 stage IIIb IV 65 choroidal 65 orthotopic 65 Histological examination 65 Resection 65 stage IIIB 65 endobronchial 65 Figure 1A 65 Peripheral Arterial 65 cells overexpressing 65 extrahepatic 65 descending thoracic 65 kidney urologic 65 superficial femoral 65 null mice 65 osteogenic 65 percutaneous biopsy 65 epithelial ovarian 65 prostate carcinomas 65 Nodules 65 recurrent metastatic 65 lymphovascular invasion 65 glomerular 65 tumors GIST 65 uricase 65 paragangliomas 65 trigeminal ganglia 65 #p# [003] 65 fibrin deposition 65 GORE TAG Device 65 LRAT 65 Atherosclerotic 65 genes differentially expressed 65 prospective multicenter study 65 adventitia 65 parotid 65 hemodynamically significant 65 plasmacytoid 65 pheochromocytoma 65 Prostatic 64 Progenitor Cells 64 proximal colon 64 pelvic lymphadenectomy 64 hilar 64 lymph node metastasis 64 urothelial cancer 64 mononuclear 64 Western blotting 64 splenic 64 HLA DQ2 64 mediastinal lymph nodes 64 Fine needle aspiration 64 Histopathological 64 chronic eosinophilic leukemia 64 chemoresistant 64 breast carcinomas 64 biopsy specimens 64 mediated inhibition 64 biochemical relapse 64 T2 weighted images 64 lactate dehydrogenase 64 choroidal neovascularization 64 Genotypes 64 pancreatic endocrine 64 Heterozygous 64 myxoid 64 carcinoembryonic antigen 64 serrated polyps 64 Randomized Study 64 adrenocortical 64 promoter methylation 64 recurrent glioblastoma multiforme 64 Cystectomy 64 1alpha 64 histologically proven 64 umbilical vein 64 PAOD 64 alkaline phosphatase ALP 64 aggrecan 64 Metastases 64 epithelioid 64 Tg mice 64 thymidylate synthase TS 64 ^ Tc 64 haematologic 64 resected 64 calculi 64 BRCA1 BRCA2 64 Parathyroid 64 advanced adenoma 64 intraventricular 64 antiproliferative effects 64 splanchnic 64 transarterial 64 inhibin B 64 metastatic lymph nodes 64 pancreatic colon 64 Tyrosine Kinase Inhibitor 64 angiographically 64 Allogeneic 64 transurethral resection 64 surgically resectable 64 artificial arteriovenous dialysis 64 esophageal gastric 64 p# mitogen activated 64 Lp PLA 2 64 chronic thromboembolic pulmonary 64 hypophosphatemia 64 pleural fluid 64 ileal 64 interleukin IL -# 64 Leukemias 64 Alkaline Phosphatase 64 histologic 64 oropharyngeal 64 antral 64 endothelial activation 64 pericardial effusion 64 transesophageal echocardiography 64 hematological relapse 64 Accelerated Partial Breast Irradiation 64 hepatic vein 64 mediastinal 64 de novo coronary artery 64 Antitumor Activity 64 sonographically guided 64 bladder prostate 64 histopathologic 64 bronchogenic 64 gastroduodenal 64 renal cell carcinomas 64 CIN2 + 64 cecal 64 squamous intraepithelial lesions 64 HER2 HER2 64 Lymphoid 64 bone marrow lymph nodes 64 CEACAM1 64 J Am Coll 64 Systemic Sclerosis 64 mineralocorticoid 64 hematoxylin 64 tunica vaginalis 64 Hepatocellular 64 Tumor Response 64 osteochondroma 64 Ribavirin causes 64 Plasma concentrations 64 ERalpha 64 Renal Artery 64 aplasia 64 Predict Response 64 Leydig cell 64 Prospective Randomized 64 subependymal giant cell 64 cytokeratin 64 upregulates 64 pulmonary metastasis 64 Polymorphism 64 schwannomas 64 treat benign prostatic 64 cytoplasmic domain 64 Alveolar 64 B Cell Lymphoma 64 peripheral blood mononuclear 64 Stage IIB 64 malignant prostate 64 ultrasonographic 64 mRNA expression 64 resistant hormone refractory 64 cytolytic activity 64 Shows Promise Against 64 tryptase 64 invasive carcinomas 64 debulking surgery 64 chromophobe 64 congenital deficiency 64 histopathological 64 eccrine 64 tumoral 64 degranulation 64 ascites fluid 64 SSc 64 type plasminogen activator 64 Combination REOLYSIN R 64 urethral stricture 64 Patients Treated With 64 Enzastaurin 64 infraspinatus 64 VATS lobectomy 63 osteoid osteoma 63 ABL1 63 matrix metalloproteinases MMPs 63 brivanib 63 endocervical 63 neuroendocrine carcinoma 63 sonographically 63 echogenicity 63 peritoneal carcinomatosis 63 gastrointestinal stromal tumors GISTs 63 pDC 63 Angiographic 63 Mutational 63 methylenetetrahydrofolate reductase 63 intraabdominal 63 primary hyperparathyroidism 63 xenograft tumors 63 CYT# potent vascular disrupting 63 Carcinomas 63 potent suppressor 63 submandibular 63 NOD SCID mice 63 Cathepsin B 63 polycythemia vera PV 63 bladder ovarian 63 CYP#A# CYP#D# 63 peripheral arterial occlusive disease 63 dorsal root ganglia 63 transurethral 63 ^ sup #m 63 intravesical infusion therapy 63 carboxy terminal 63 node metastasis 63 Fas ligand 63 arteriolar 63 hepatocellular carcinoma liver 63 sulcal 63 Adjuvant Chemotherapy 63 neoplasm 63 multivariate Cox 63 Tie2 63 relapsed MM 63 molecule epidermal 63 polypoid 63 heterozygotes 63 rs# [004] 63 FDG PET imaging 63 Lobular 63 immunocytochemistry 63 Hemangiomas 63 histological diagnosis 63 Monocyte 63 plasmid encoding 63 tubular atrophy 63 hydronephrosis 63 prostate cancer CaP 63 T1 weighted images 63 adrenalectomy 63 Calcification 63 para aortic 63 prostatic tissue 63 ovarian carcinoma 63 hypothalamic pituitary 63 intratumoral 63 clinicopathological features 63 paraffin embedded 63 CD3 + 63 esophagus bladder 63 Asymptomatic 63 aneurysmal 63 neoplastic 63 localized renal 63 Testis 63 neurological manifestations 63 intraperitoneal injection 63 acid phosphatase PAP 63 irreversible inhibitor 63 prostate bladder 63 bladder carcinoma 63 LNCaP 63 ventricular septum 63 bronchial epithelial cells 63 MMP# 63 carboxyl terminal 63 parathyroid 63 metastatic pancreatic 63 lung carcinomas 63 pancreatic neuroendocrine 63 tracheobronchial 63 metachronous 63 neoplasias 63 MR Angiography 63 intrathoracic 63 mL/min/#.# m 2 63 Parathyroid Hormone 63 perineural invasion 63 locoregional recurrence 63 SHANK3 63 antiphospholipid antibodies 63 formalin fixed 63 5 hydroxytryptamine 63 Annexin V 63 mRNA encoding 63 gastric carcinoma 63 adipogenic 63 plasma pharmacokinetics 63 basal epithelial 63 Relapsed Refractory 63 keloid scarring 63 Angiotensin Converting Enzyme 63 paraganglioma 63 idiopathic membranous nephropathy 63 lymph node metastases 63 carcinoids 63 ERK1 2 63 microvessel density 63 malignant neoplasm 63 TRAIL receptors 63 colorectum 63 microsatellite instability 63 hemorrhage necrosis 63 retinal ischemia 63 pancreas esophagus 63 CD# expression [001] 63 Oral Fingolimod 63 transthoracic 63 papillary 63 uterus fallopian tubes 63 Duodenal 63 basal cell carcinoma BCC 63 Glycosylation 63 Thromboembolic 63 annexin 63 chromosome #q#.# [002] 63 polycythemia vera essential thrombocythemia 63 coronary stenosis 63 multicenter Phase II 63 ascending aortic 63 potent inducer 63 β1 63 underwent radical prostatectomy 63 stent stenosis 63 cyclin dependent kinase inhibitor 63 hematopoietic progenitor cells 63 p# biomarker 63 pulmonary alveolar 63 HER2 amplification 63 biliary tree 63 alpha1 proteinase inhibitor 63 deoxy 63 metastatic colorectal 63 novel VDA molecule 63 fractional shortening 63 Prognostic significance 63 specific antigen PSA 63 VP# [004] 63 lymphocytosis 63 demonstrated antitumor activity 63 carcinoid tumors 63 hypereosinophilic syndrome 63 Squamous Cell Carcinoma 63 HG PIN 63 bronchogenic carcinoma 63 invasive lobular 63 graft occlusion 63 1α 63 Histone deacetylase 63 ADPKD 63 ultrastructural 63 urate oxidase 63 intraoperative complications 63 #F FDG PET 63 nodular lesions 63 cyclooxygenase COX 63 Cytotoxic T 63 cytologic 63 KRAS oncogene 63 neuritic 63 lacunar 63 microdissected 63 Phase 2b Clinical Trial 63 #F FDG 63 Mouse Models 63 androgen receptor AR 63 xenograft 63 transthyretin amyloidosis 63 axilla 63 neoplastic cells 63 CD# CD# 63 insulin secreting 63 Peritoneal 63 transcranial Doppler ultrasound 63 computed tomographic scan 63 HepG2 63 neovasculature 63 Subarachnoid hemorrhage 63 transiently transfected 63 non resectable metastatic 63 embryonal carcinoma 63 Carotid 63 anterior pituitary 63 Proc Am Soc 63 PLX STROKE targeting 63 TMPRSS2 ERG 63 thymidine kinase 63 Embolic 63 morphologic characteristics 62 choroidal neovascularization CNV 62 bFGF 62 malignant pancreatic 62 ischemia driven 62 #:#-# [029] 62 biopsy specimen 62 endoscopic resection 62 cervical carcinoma 62 duplex ultrasonography 62 monocytic 62 steroidogenic 62 Kir#.# 62 lysophosphatidic acid 62 dysplastic 62 supraclavicular 62 topoisomerase II inhibitor 62 LPS induced 62 Refractory Hodgkin Lymphoma 62 mU liter 62 Esophageal 62 prostate epithelial cells 62 abnormal p# 62 Atypical Hemolytic Uremic Syndrome 62 hypogonadotropic hypogonadism 62 reflux esophagitis 62 refractory chronic lymphocytic 62 generation antisense inhibitor 62 gene polymorphisms 62 scintigraphic 62 ipsilateral breast 62 IIIA NSCLC 62 CD# expression [002] 62 distant metastasis 62 colorectal gastric 62 periventricular 62 Pharmacokinetics PK 62 induced apoptosis 62 Castration Resistant Prostate Cancer 62 Corynebacterium 62 Clinical Outcome 62 MTHFR 62 Lymph node 62 clinico pathological 62 lung nodule 62 tumor infiltrating lymphocytes 62 substantially excreted 62 Immunomodulatory 62 4E BP1 62 hepatomegaly 62 Neoplasms 62 precursor lesions 62 liver colon rectal 62 tumor necrosis 62 pancreatic adenocarcinoma 62 germline mutation 62 EGFR mutant 62 Doppler echocardiography 62 Supplementary Table 62 Preoperative 62 Anaplastic 62 Cutaneous 62 Inactivation 62 osteoid 62 transvaginal sonography 62 Ultrasonography 62 intrahepatic bile duct 62 Am J Cardiol 62 Human Leukocyte Antigen 62 advanced pancreatic neuroendocrine 62 CLL SLL 62 fluconazole resistant 62 Immunohistochemical 62 ileum 62 myopathies 62 Chronic HCV 62 perianal 62 Oncogenic 62 International Prognostic Scoring 62 longus tendon 62 allelic variants 62 RhuDex R 62 hepatic enzyme 62 pretreatment serum 62 fallopian tube cancers 62 thyroglobulin 62 hepatorenal syndrome 62 castrate resistant 62 SCID mice 62 resectable 62 metastatic adenocarcinoma 62 sonographic appearance 62 platelet dysfunction 62 eosin 62 aurora kinase 62 PNET 62 malignant lymphoma 62 p# deficient 62 sunitinib Sutent 62 prostatic 62 Phospholipase 62 Proliferative 62 BRAF V#E mutation 62 antiproliferative activity 62 vagina cervix 62 transaminase 62 patientswith 62 Patency 62 BrachySil ™ 62 florbetaben 62 upper endoscopy 62 squamous cell carcinoma SCC 62 lexidronam injection 62 J Am Soc 62 Osteomyelitis 62 bladder tumors 62 hyperintensity 62 computed tomographic 62 Xenografts 62 hyaluronidase enzyme 62 TO AVOID PREGNANCY WHILE 62 hypervascular tumors 62 pharynx larynx 62 Prolongs Survival 62 aminotransferase levels 62 soluble tumor necrosis 62 Dehydrogenase 62 sinonasal 62 intraperitoneally 62 metabolizing enzyme 62 protein tyrosine phosphatase 1B 62 perivascular 62 Interferon gamma 62 Alanine 62 lymphoid tissue 62 peri implant 62 osteolytic 62 lymphadenectomy 62 IL8 62 Epithelial 62 serine protease 62 ErbB2 positive 62 bladder cervix 62 CpG island 62 homogenates 62 Antithrombin 62 Pathologic 62 thromboembolic complications 62 thyroid carcinomas 62 hepatocellular 62 fasting plasma 62 isolated perfused 62 supernatants 62 SGPT 62 luminal 62 PLA2 62 FGFR3 62 EGFR mutation positive 62 pleurodesis 62 fibrosarcoma 62 ® lenalidomide 62 squamous carcinoma 62 metastatic bladder 62 Ph + acute lymphoblastic 62 TRAIL R2 62 EGFR TK 62 carotid artery intima media 62 5alpha reductase 62 extracranial 62 axillary lymph nodes 62 osteoblastic 62 Phosphorylation 62 hepatic enzymes 62 lymphocytic 62 Diffuse Large B 62 intradermal injections 62 trial evaluating PRX# 62 Intracoronary 62 Endothelial Cells 62 adenocarcinomas 62 decarboxylase 62 TP# mutations 62 prostanoid 62 myometrium 62 B7 H3 62 ribosomal protein 62 transrectal ultrasound guided 62 metastatic lesion 62 recurrent squamous cell carcinoma 62 Aeromonas 62 breast ovary 62 pyelonephritis 62 TGF alpha 62 lymphoid malignancies 62 lobule 62 BRAF gene mutations 62 cTnI 62 HepDirect prodrug 62 recurrent ovarian 62 MMP2 62 tumor histology 62 diabetes mellitus DM 62 serum prostate 62 HIF 1α 62 Neovascularization 62 aspartate aminotransferase AST 62 immunoreactivity 62 intimal hyperplasia 62 ultrastructure 62 vWF 62 intraobserver 62 adrenocortical cancer 62 alpha1 62 MLH1 62 histopathological examination 62 malignant ascites 62 Placebo Controlled Trial 62 Preclinical Study 62 treating abdominal aortic 62 Distal 62 MGd 62 Hypertrophic 62 preoperative diagnosis 62 CDH1 62 Cancer Incidence Mortality 62 Supplementary Appendix 62 constitutively active 62 renal biopsy 62 Histone 62 Occlusive Disease 62 Antiangiogenic 62 ERK signaling 62 intracavitary 62 obstructive coronary 62 Immunohistochemistry 62 node metastases 62 pulmonary artery banding 62 transverse colon 62 chromosomal mutations 62 epithelial cells lining 62 cerebrospinal fluid CSF 62 extramedullary 62 nonischemic 62 ovary uterus 62 liver resection 62 SUVmax 62 neoplastic lesions 62 Randomized Phase II 62 underlying vasculopathy 62 HLA DR4 62 metastatic androgen independent 62 baseline LDH 62 peroxisomal 62 stage IIIA 62 Antitumor 62 synovial tissue 62 Î ² 62 nodular 62 basal cell skin 62 duodenal 62 dorsal root 62 vitreous floaters 62 chorionic villi 62 arteriography 62 #m Tc 62 intravesical therapy 62 c KIT 62 Legg Calvé Perthes disease 62 Varicella zoster virus 62 essential thrombocythemia 62 Neurosurgical Products 62 Prognostic factors 62 granulosa cell 62 germline mutations 62 integrin alpha 62 fosbretabulin 62 bevacizumab Avastin R 62 bronchoalveolar 62 Epidermal Growth Factor Receptor 62 malignant fibrous histiocytoma 62 osteosarcomas 62 TUNEL 62 infrapopliteal 62 anemia thrombocytopenia 61 TOP2A gene 61 ventricular myocardium 61 uterine tumors 61 experimental autoimmune encephalomyelitis 61 #:#-# [031] 61 humanised antibody 61 adnexal mass 61 Situ Hybridization 61 artery occlusion 61 radioligand 61 seropositivity 61 renal carcinoma 61 osteoprotegerin 61 opacification 61 ara C 61 nondiabetic patients 61 atypical hyperplasia 61 lobular 61 Stromal 61 granulomatous 61 potently inhibited 61 Diabetic nephropathy 61 C#BL 6 mice 61 sitosterol 61 epithelial tumors 61 Subtypes 61 haematopoietic stem cell 61 ANCA associated 61 F FDG PET 61 novel emulsion formulation 61 submandibular gland 61 serum aminotransferase levels 61 procollagen 61 proto oncogene 61 R Saizen R 61 CCR9 61 Leydig cells 61 Hepatic 61 ultrasonographic examination 61 elevated LDH 61 MALT lymphoma 61 Hypercholesterolemia 61 Parathyroid hormone 61 superior mesenteric artery 61 ethmoid 61 obscure gastrointestinal bleeding 61 laser capture microdissection 61 hypoplastic 61 malignant cancerous 61 protein secreted 61 Interstitial 61 lymphoid cells 61 lesional 61 dysgenesis 61 PTPN# 61 hypercalciuria 61 femoral popliteal 61 Vertebral 61 Cardiol 61 CCR5 delta# 61 MDA MB 61 plasminogen activator inhibitor 61 Xenograft 61 fibrosing 61 lung ovary 61 IN PATIENTS WITH 61 endoluminal stent graft 61 protein tyrosine phosphatase 61 Bacteremia 61 polymorphonuclear 61 Valvular 61 Factor Receptor 61 Hippocampal 61 Sjögren syndrome 61 microsomal 61 infiltrating ductal carcinoma 61 VEGF induced 61 Transmembrane